Functional and Cognitive Impairment in Patients with Relapsing–Remitting Multiple Sclerosis: Cognitive Tests and Plasma Neurofilament Light Chain Levels

<i>Background and Objectives:</i> Multiple sclerosis (MS) is a chronic inflammatory, autoimmune, and neurodegenerative disease of the central nervous system. The disease can manifest and progress with both physical and cognitive symptoms, affecting the patient’s daily activities. The aim...

Full description

Saved in:
Bibliographic Details
Main Authors: Elina Polunosika, Joel Simren, Arta Akmene, Nikita Klimovskis, Kaj Blennow, Daina Pastare, Henrik Zetterberg, Renars Erts, Guntis Karelis
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/61/1/70
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587991312236544
author Elina Polunosika
Joel Simren
Arta Akmene
Nikita Klimovskis
Kaj Blennow
Daina Pastare
Henrik Zetterberg
Renars Erts
Guntis Karelis
author_facet Elina Polunosika
Joel Simren
Arta Akmene
Nikita Klimovskis
Kaj Blennow
Daina Pastare
Henrik Zetterberg
Renars Erts
Guntis Karelis
author_sort Elina Polunosika
collection DOAJ
description <i>Background and Objectives:</i> Multiple sclerosis (MS) is a chronic inflammatory, autoimmune, and neurodegenerative disease of the central nervous system. The disease can manifest and progress with both physical and cognitive symptoms, affecting the patient’s daily activities. The aim of our study was to investigate the correlation between functional status, cognitive functions, and neurofilament light chain levels in plasma in MS patients. <i>Materials and Methods:</i> In a cross-sectional study, MS patients with a relapsing–remitting course (according to McDonald’s criteria, 2017) (<i>n</i> = 42) from Riga East University Hospital and a control group (<i>n</i> = 42) were included. In the MS group, the functional status was determined using the Expanded Disability Status Scale (EDSS), and neurofilament light chain levels in plasma (pNfL) were detected using single molecule array (Simoa) technology. The symbol digit modalities test (SDMT), brief visuospatial memory test—revised (BVMT-R), and the nine-hole peg test (9-HPT) were performed on the MS and control groups, dividing the groups by education level. <i>Results:</i> On the SDMT spreading speed, the MS group performed worse than the control group. The median score for the control group was 94.0, and for the MS group, it was 81.3. Slower performance on the SDMT also correlated with a higher EDSS in the MS group. Cognitive processing speed and memory were better in the control group and among individuals with higher education in both groups. For the BVMT-R, we found no difference between the two groups; both groups were able to learn the task equally well, but we found a weak correlation between age and learning in both groups, which could be related to the normal aging process. Execution reaction speed on the 9-HPT with the dominant hand was slower in the MS group (24.1 s) than in the control group (19.4 s). In the MS group, we observed a trend between SDMT performance and pNfL levels: higher pNfL levels were found in individuals who performed more slowly on the SDMT. <i>Conclusions:</i> Cognitive and fine motor dysfunction correlates with neurological impairment and plasma neurofilament light chain levels in MS patients.
format Article
id doaj-art-5301e35beccc4bedb88aecb80fcf31c5
institution Kabale University
issn 1010-660X
1648-9144
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj-art-5301e35beccc4bedb88aecb80fcf31c52025-01-24T13:40:28ZengMDPI AGMedicina1010-660X1648-91442025-01-016117010.3390/medicina61010070Functional and Cognitive Impairment in Patients with Relapsing–Remitting Multiple Sclerosis: Cognitive Tests and Plasma Neurofilament Light Chain LevelsElina Polunosika0Joel Simren1Arta Akmene2Nikita Klimovskis3Kaj Blennow4Daina Pastare5Henrik Zetterberg6Renars Erts7Guntis Karelis8Department of Neurology and Neurosurgery, Riga East University Hospital, LV-1038 Riga, LatviaDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, 40530 Molndal, SwedenDepartment of Neurology and Neurosurgery, Riga East University Hospital, LV-1038 Riga, LatviaFaculty of Medicine, Riga Stradinš University, LV-1007 Riga, LatviaDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, 40530 Molndal, SwedenDepartment of Neurology and Neurosurgery, Riga East University Hospital, LV-1038 Riga, LatviaDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, 40530 Molndal, SwedenFaculty of Medicine and Life Sciences, University of Latvia, LV-1050 Riga, LatviaDepartment of Neurology and Neurosurgery, Riga East University Hospital, LV-1038 Riga, Latvia<i>Background and Objectives:</i> Multiple sclerosis (MS) is a chronic inflammatory, autoimmune, and neurodegenerative disease of the central nervous system. The disease can manifest and progress with both physical and cognitive symptoms, affecting the patient’s daily activities. The aim of our study was to investigate the correlation between functional status, cognitive functions, and neurofilament light chain levels in plasma in MS patients. <i>Materials and Methods:</i> In a cross-sectional study, MS patients with a relapsing–remitting course (according to McDonald’s criteria, 2017) (<i>n</i> = 42) from Riga East University Hospital and a control group (<i>n</i> = 42) were included. In the MS group, the functional status was determined using the Expanded Disability Status Scale (EDSS), and neurofilament light chain levels in plasma (pNfL) were detected using single molecule array (Simoa) technology. The symbol digit modalities test (SDMT), brief visuospatial memory test—revised (BVMT-R), and the nine-hole peg test (9-HPT) were performed on the MS and control groups, dividing the groups by education level. <i>Results:</i> On the SDMT spreading speed, the MS group performed worse than the control group. The median score for the control group was 94.0, and for the MS group, it was 81.3. Slower performance on the SDMT also correlated with a higher EDSS in the MS group. Cognitive processing speed and memory were better in the control group and among individuals with higher education in both groups. For the BVMT-R, we found no difference between the two groups; both groups were able to learn the task equally well, but we found a weak correlation between age and learning in both groups, which could be related to the normal aging process. Execution reaction speed on the 9-HPT with the dominant hand was slower in the MS group (24.1 s) than in the control group (19.4 s). In the MS group, we observed a trend between SDMT performance and pNfL levels: higher pNfL levels were found in individuals who performed more slowly on the SDMT. <i>Conclusions:</i> Cognitive and fine motor dysfunction correlates with neurological impairment and plasma neurofilament light chain levels in MS patients.https://www.mdpi.com/1648-9144/61/1/70multiple sclerosisneurofilamentSDMTEDSSBVMT-RpNfL
spellingShingle Elina Polunosika
Joel Simren
Arta Akmene
Nikita Klimovskis
Kaj Blennow
Daina Pastare
Henrik Zetterberg
Renars Erts
Guntis Karelis
Functional and Cognitive Impairment in Patients with Relapsing–Remitting Multiple Sclerosis: Cognitive Tests and Plasma Neurofilament Light Chain Levels
Medicina
multiple sclerosis
neurofilament
SDMT
EDSS
BVMT-R
pNfL
title Functional and Cognitive Impairment in Patients with Relapsing–Remitting Multiple Sclerosis: Cognitive Tests and Plasma Neurofilament Light Chain Levels
title_full Functional and Cognitive Impairment in Patients with Relapsing–Remitting Multiple Sclerosis: Cognitive Tests and Plasma Neurofilament Light Chain Levels
title_fullStr Functional and Cognitive Impairment in Patients with Relapsing–Remitting Multiple Sclerosis: Cognitive Tests and Plasma Neurofilament Light Chain Levels
title_full_unstemmed Functional and Cognitive Impairment in Patients with Relapsing–Remitting Multiple Sclerosis: Cognitive Tests and Plasma Neurofilament Light Chain Levels
title_short Functional and Cognitive Impairment in Patients with Relapsing–Remitting Multiple Sclerosis: Cognitive Tests and Plasma Neurofilament Light Chain Levels
title_sort functional and cognitive impairment in patients with relapsing remitting multiple sclerosis cognitive tests and plasma neurofilament light chain levels
topic multiple sclerosis
neurofilament
SDMT
EDSS
BVMT-R
pNfL
url https://www.mdpi.com/1648-9144/61/1/70
work_keys_str_mv AT elinapolunosika functionalandcognitiveimpairmentinpatientswithrelapsingremittingmultiplesclerosiscognitivetestsandplasmaneurofilamentlightchainlevels
AT joelsimren functionalandcognitiveimpairmentinpatientswithrelapsingremittingmultiplesclerosiscognitivetestsandplasmaneurofilamentlightchainlevels
AT artaakmene functionalandcognitiveimpairmentinpatientswithrelapsingremittingmultiplesclerosiscognitivetestsandplasmaneurofilamentlightchainlevels
AT nikitaklimovskis functionalandcognitiveimpairmentinpatientswithrelapsingremittingmultiplesclerosiscognitivetestsandplasmaneurofilamentlightchainlevels
AT kajblennow functionalandcognitiveimpairmentinpatientswithrelapsingremittingmultiplesclerosiscognitivetestsandplasmaneurofilamentlightchainlevels
AT dainapastare functionalandcognitiveimpairmentinpatientswithrelapsingremittingmultiplesclerosiscognitivetestsandplasmaneurofilamentlightchainlevels
AT henrikzetterberg functionalandcognitiveimpairmentinpatientswithrelapsingremittingmultiplesclerosiscognitivetestsandplasmaneurofilamentlightchainlevels
AT renarserts functionalandcognitiveimpairmentinpatientswithrelapsingremittingmultiplesclerosiscognitivetestsandplasmaneurofilamentlightchainlevels
AT guntiskarelis functionalandcognitiveimpairmentinpatientswithrelapsingremittingmultiplesclerosiscognitivetestsandplasmaneurofilamentlightchainlevels